Brief: Telix Pharmaceuticals Announces Proposed Acquisition Of QSAM Biosciences
14/11/2023 24:30
Nov 14 (Reuters) - Qsam Biosciences Inc QSAM.PK :
* TELIX ANNOUNCES PROPOSED ACQUISITION OF QSAM BIOSCIENCES
* SIGNED A CONDITIONAL TERM SHEET TO ACQUIRE QSAM
BIOSCIENCES,
INC. AND ITS LEAD ASSET, CYCLOSAM
* WILL PAY PURCHASE PRICE OF US$33.1 MILLION IN EQUITY
THROUGH
ISSUE OF FULLY PAID ORDINARY SHARES
Source text for Eikon: ID:nASX5LFTT9
Further company coverage: QSAM.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qsam Biosciences
See all newsBrief: QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals
Brief: Qsam Biosciences Says Co Granted Telix An Additional 30 Days Under Exclusivity Period To Complete Its Due Diligence
Brief: Qsam Biosciences Signs Term Sheet To Be Acquired By Telix Pharmaceuticals Receives $2 Million Pre-Closing Collaboration And Option Fee
Brief: Telix Pharmaceuticals Announces Proposed Acquisition Of QSAM Biosciences
Brief: Qsam Biosciences Provides Update To Shareholders On Phase 1 Progress And Preliminary Clinical Data